← Leaderboards
Abrar A Qureshi
Massachusetts General Hospital
$2,487,735
Attributed
$2,487,735
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $510.3K · FY2006–13$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,487,735 · 7
By mechanism
R01$1,434,605 · 1
K07$746,715 · 1
R03$175,000 · 1
F32$110,160 · 1
M01$21,255 · 3
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- David E Fisher$28,420,496
- Anne Louise Oaklander$9,980,414
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortRisk FactorsHealth StudyLaboratoriesSkin CancerMelanomaMorbidity - Disease RateNurses&AposTrainingSkinPatient Self-ReportResponseClassificationSunburnSquamous Cell CarcinomaSun ExposureUltraviolet RaysCancer RiskBasal Cell CarcinomaPopulation BasedRecording Of Previous EventsBaseResearch PersonnelCutaneous Melanoma
Grant awards (18)
Molecular signatures of melanoma histology and progression: A Population Based A$270,178
R01 · FY2013 · CA · contact PI
Molecular signatures of melanoma histology and progression: A Population Based A$287,421
R01 · FY2012 · CA · contact PI
Molecular signatures of melanoma histology and progression: A Population Based A$287,153
R01 · FY2011 · CA · contact PI
Molecular signatures of melanoma histology and progression: A Population Based A$295,480
R01 · FY2010 · CA · contact PI
Population-Based Approach to Skin Cancer Epidemiology$114,281
K07 · FY2010 · CA · contact PI
Molecular signatures of melanoma histology and progression: A Population Based A$294,373
R01 · FY2009 · CA · contact PI
Population-Based Approach to Skin Cancer Epidemiology$111,854
K07 · FY2009 · CA · contact PI
Population-Based Approach to Skin Cancer Epidemiology$104,120
K07 · FY2009 · CA · contact PI
Population-Based Approach to Skin Cancer Epidemiology$138,820
K07 · FY2008 · CA · contact PI
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer$87,500
R03 · FY2008 · CA · contact PI
PSORIATIC ARTHRITIS AND PSORIASIS FOLLOW-UP STUDY$2,189
M01 · FY2008 · RR · contact PI
Population-Based Approach to Skin Cancer Epidemiology$138,820
K07 · FY2007 · CA · contact PI
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer$87,500
R03 · FY2007 · CA · contact PI
PSORIATIC ARTHRITIS AND PSORIASIS FOLLOW-UP STUDY$14,669
M01 · FY2007 · RR · contact PI
Population-Based Approach to Skin Cancer Epidemiology$138,820
K07 · FY2006 · CA · contact PI
PSORIATIC ARTHRITIS AND PSORIASIS FOLLOW-UP STUDY$4,397
M01 · FY2006 · RR · contact PI
Outcomes approach clinical problems in dermatology$56,308
F32 · FY2004 · AR
Outcomes approach clinical problems in dermatology$53,852
F32 · FY2002 · AR